Evidence map›Paper›PMID 25275221›Full record

SynthesisJournal of alternative and complementary medicine (New York, N.Y.)2015

Antioxidant and associated capacities of Camu camu (Myrciaria dubia): a systematic review.

Paul C Langley, Joseph V Pergolizzi, Robert Taylor, Caroline Ridgway

Registry-linked trialOpen access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Journal of alternative and complementary medicine (New York, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04103099 (Evaluation of the Impact of the HLNatural, Inc. Immune Support Product in Reducing the Length of Cold Symptoms in Adults Suffering From the Common Cold), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04103099 nacompletednot on this mapstarted 2019, after this paper: background citation

Evaluation of the Impact of the HLNatural, Inc. Immune Support Product in Reducing the Length of Cold Symptoms in Adults Suffering From the Common Cold

TypeinterventionalSponsorHawthorne Effect Inc.Ran2019 to 2020Enrolled200ConditionsImmune System DiseasesArmsHLNatural Immune
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Foods (Basel, Switzerland) · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Anti-Allergic Effects ofAntioxidants (Basel, Switzerland) · 2021
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Paul C Langley1 Maimon Research LLC , Tucson, AZ.
Joseph V Pergolizzi
Robert Taylor
Caroline Ridgway
Amazon (United States) · USAmerican Institute for Maghrib Studies · USGeorgetown University · USNema Research (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An aging population in the United States presents important challenges for patients and physicians. The presence of inflammation can contribute to an accelerated aging process, the increasing presence of comorbidities, oxidative stress, and an increased prevalence of chronic pain. As patient-centered care is embracing a multimodal, integrative approach to the management of disease, patients and physicians are increasingly looking to the potential contribution of natural products. Camu camu, a well-researched and innovative natural product, has the potential to contribute, possibly substantially, to this management paradigm. The key issue is to raise camu camu's visibility through increased emphasis on its robust evidentiary base and its various formulations, as well as making consumers, patients, and physicians more aware of its potential. A program to increase the visibility of camu camu can contribute substantially not only to the management of inflammatory conditions and its positive contribution to overall good health but also to its potential role in many disease states.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsCell LineHumansMyrtaceaePlant ExtractsAnti-Inflammatory AgentsAntioxidantsPlant Extracts

Identifiers

PMID25275221
PMCPMC4296744
OpenAlexW1561063329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.